Search

Additional file 1: Figure S1. Evaluation for working antigen concentration of PEDV. For optimization of working PEDV antigen concentration, 3 NT positive sera (1: 128, 1:64, 1:8 of NT titer) and 3 NT negative sera (1

Additional file 2: Figure S2. Evaluation for working serum samples dilution. Three NT positive (1: 128, 1:64, 1:8 of NT titer) and 3 NT negative sera (1

Table S1. Highly-specific N-glycosylation sites in the spike protein of the vaccine and field strains. (DOCX 13 kb)

Figure S2. Aligment of deduced S amino acid sequences of Japanese PEDVs from primary and recurent outbreaks. The deduced S protein of 14JM-168 had 11 amino acid substitutions (T211I, V312 M, A477S, K566 N, D569Y, G612D, E626D, F635 L, S722 N, T777 M, G888D) compared to those of 16JM-334 and 16JM-339. Deduced S proteins of 14JM-179, 14JM-181, 14JM-199, and 14JM-200 had 13 amino acid substitutions (Y6H, T24A, A311T, F345 V, T367 N, L416F, H524L, K587R, V674F, S925A, S968A, N1009S, and I1067M) compared to those of 16JM-319 and 16JM-326. (PDF 371 kb)

Serum autoantibody profiles of PM/DM patients in this study. (DOCX 51Â kb)

The glomerulus score. Table S2. The score of cell-infiltration level. Table S3. The primers used for this study. Table S4. Expression levels of genes associated with the interferon (IFN) signaling pathway in splenic CD4+ T cells from BWF1 mice. (DOCX 27 kb)